AYOXXA Biosystems
Latest round
- Series B
Last raised
- Dec 2014
Total raised
- $19M
Investors
- 11
About AYOXXA Biosystems
AYOXXA Biosystems GmbH, founded in 2010 in Cologne, Germany, specializes in advanced diagnostic platforms.30 mn from BioMed Partners and Grazia Equity on March 14, 2022.AYOXXA specializes in the development and provision of innovative diagnostic solutions aimed at enhancing biomarker analysis and diagnostic processes. Their core product offerings include a proprietary multiplex protein detection platform designed for high-throughput analysis of biomarkers in various biological samples. This technology supports critical applications in personalized medicine, drug development, and clinical diagnostics, providing rapid and accurate health insights for healthcare professionals and researchers.AYOXXA's revenue primarily comes from sales of its diagnostic platforms and associated consumables, which are essential for biomarker analysis. The company engages in B2B transactions where clients purchase necessary equipment and reagents. Partnerships with research institutions and healthcare organizations integrate AYOXXA's technology into diagnostic workflows, with pricing plans tailored to client needs.30 mn to drive the global commercialization of its LUNARIS(TM) platform. The company plans to expand its product lineup and is targeting growth in new markets beyond Europe and North America, although specific regions or timelines have yet to be disclosed.
Who invested in AYOXXA Biosystems
11 investors across 3 rounds
See all investors in AYOXXA Biosystems
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AYOXXA Biosystems
Who invested in AYOXXA Biosystems?
AYOXXA Biosystems has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AYOXXA Biosystems raised?
AYOXXA Biosystems has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did AYOXXA Biosystems last raise money?
AYOXXA Biosystems's most recent round on record is a Series B, in Dec 2014.
What does AYOXXA Biosystems do?
AYOXXA Biosystems GmbH, founded in 2010 in Cologne, Germany, specializes in advanced diagnostic platforms.
Where is AYOXXA Biosystems headquartered?
AYOXXA Biosystems is headquartered in Cologne, Germany.
Which VCs invest in companies like AYOXXA Biosystems?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at AYOXXA Biosystems's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like AYOXXA Biosystems? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.